Logo image of DRIO

DARIOHEALTH CORP (DRIO) Stock Fundamental Analysis

USA - NASDAQ:DRIO - US23725P3082 - Common Stock

7.35 USD
+0.75 (+11.36%)
Last: 9/22/2025, 12:58:25 PM
Fundamental Rating

3

Taking everything into account, DRIO scores 3 out of 10 in our fundamental rating. DRIO was compared to 35 industry peers in the Health Care Technology industry. While DRIO seems to be doing ok healthwise, there are quite some concerns on its profitability. DRIO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DRIO had negative earnings in the past year.
DRIO had a negative operating cash flow in the past year.
In the past 5 years DRIO always reported negative net income.
DRIO had a negative operating cash flow in each of the past 5 years.
DRIO Yearly Net Income VS EBIT VS OCF VS FCFDRIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -39.18%, DRIO is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
DRIO's Return On Equity of -66.33% is on the low side compared to the rest of the industry. DRIO is outperformed by 65.71% of its industry peers.
Industry RankSector Rank
ROA -39.18%
ROE -66.33%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
DRIO Yearly ROA, ROE, ROICDRIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600 -800

1.3 Margins

DRIO's Gross Margin of 54.98% is in line compared to the rest of the industry. DRIO outperforms 48.57% of its industry peers.
DRIO's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for DRIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
DRIO Yearly Profit, Operating, Gross MarginsDRIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

4

2. Health

2.1 Basic Checks

DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
DRIO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DRIO has more shares outstanding
DRIO has a better debt/assets ratio than last year.
DRIO Yearly Shares OutstandingDRIO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DRIO Yearly Total Debt VS Total AssetsDRIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

DRIO has an Altman-Z score of -6.04. This is a bad value and indicates that DRIO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -6.04, DRIO is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.48 indicates that DRIO is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.48, DRIO is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z -6.04
ROIC/WACCN/A
WACC12.56%
DRIO Yearly LT Debt VS Equity VS FCFDRIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

A Current Ratio of 3.30 indicates that DRIO has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.30, DRIO is doing good in the industry, outperforming 74.29% of the companies in the same industry.
DRIO has a Quick Ratio of 2.83. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of DRIO (2.83) is better than 68.57% of its industry peers.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 2.83
DRIO Yearly Current Assets VS Current LiabilitesDRIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

DRIO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -373.12%.
The Revenue has grown by 41.77% in the past year. This is a very strong growth!
The Revenue has been growing by 29.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-373.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
Revenue 1Y (TTM)41.77%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-14.16%

3.2 Future

The Earnings Per Share is expected to grow by 17.22% on average over the next years. This is quite good.
DRIO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.06% yearly.
EPS Next Y94.37%
EPS Next 2Y37.83%
EPS Next 3Y23.06%
EPS Next 5Y17.22%
Revenue Next Year-9.66%
Revenue Next 2Y21.09%
Revenue Next 3Y12.32%
Revenue Next 5Y18.06%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DRIO Yearly Revenue VS EstimatesDRIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
DRIO Yearly EPS VS EstimatesDRIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DRIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DRIO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRIO Price Earnings VS Forward Price EarningsDRIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRIO Per share dataDRIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

DRIO's earnings are expected to grow with 23.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.83%
EPS Next 3Y23.06%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DRIO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DARIOHEALTH CORP

NASDAQ:DRIO (9/22/2025, 12:58:25 PM)

7.35

+0.75 (+11.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners16.6%
Inst Owner Change-4.49%
Ins Owners8.34%
Ins Owner Change15.45%
Market Cap17.64M
Analysts82
Price Target26.18 (256.19%)
Short Float %N/A
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.36%
Min EPS beat(2)-17.64%
Max EPS beat(2)24.37%
EPS beat(4)3
Avg EPS beat(4)22.65%
Min EPS beat(4)-17.64%
Max EPS beat(4)73.53%
EPS beat(8)6
Avg EPS beat(8)29.38%
EPS beat(12)9
Avg EPS beat(12)23.21%
EPS beat(16)10
Avg EPS beat(16)17.25%
Revenue beat(2)0
Avg Revenue beat(2)-17.61%
Min Revenue beat(2)-23.78%
Max Revenue beat(2)-11.45%
Revenue beat(4)1
Avg Revenue beat(4)-8.98%
Min Revenue beat(4)-23.78%
Max Revenue beat(4)0.92%
Revenue beat(8)1
Avg Revenue beat(8)-13.89%
Revenue beat(12)4
Avg Revenue beat(12)-8.68%
Revenue beat(16)5
Avg Revenue beat(16)-7.65%
PT rev (1m)877.78%
PT rev (3m)877.78%
EPS NQ rev (1m)-3738%
EPS NQ rev (3m)-2327.38%
EPS NY rev (1m)0%
EPS NY rev (3m)41.72%
Revenue NQ rev (1m)-13.83%
Revenue NQ rev (3m)-26.38%
Revenue NY rev (1m)-9.27%
Revenue NY rev (3m)-19.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.65
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-13.2
EYN/A
EPS(NY)-0.86
Fwd EYN/A
FCF(TTM)-11.22
FCFYN/A
OCF(TTM)-11.16
OCFYN/A
SpS11.31
BVpS26.66
TBVpS-4.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.18%
ROE -66.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.98%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
F-Score4
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.03%
Cap/Sales 0.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 2.83
Altman-Z -6.04
F-Score4
WACC12.56%
ROIC/WACCN/A
Cap/Depr(3y)8.55%
Cap/Depr(5y)19.33%
Cap/Sales(3y)1.81%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-373.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
EPS Next Y94.37%
EPS Next 2Y37.83%
EPS Next 3Y23.06%
EPS Next 5Y17.22%
Revenue 1Y (TTM)41.77%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-14.16%
Revenue Next Year-9.66%
Revenue Next 2Y21.09%
Revenue Next 3Y12.32%
Revenue Next 5Y18.06%
EBIT growth 1Y32.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.48%
EBIT Next 3Y25.71%
EBIT Next 5Y16.13%
FCF growth 1Y19.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.88%
OCF growth 3YN/A
OCF growth 5YN/A